NF Trinity Capital’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
NF Trinity Capital's XBI Position: Q2 2018 in Review
NF Trinity Capital sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2018, closing a stake of 119,000 shares — an estimated $10.4M sold.
NF Trinity Capital first reported a position in XBI in Q3 2017 and held it in 3 quarters. The position peaked at $10.4M in Q1 2018. 431 funds tracked by Wall St. Rank hold XBI as of Q2 2018.
- NF Trinity Capital reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2018 after selling out during the quarter.
- NF Trinity Capital sold 119,000 State Street SPDR S&P Biotech ETF shares in Q2 2018, an estimated $10.4M.
- NF Trinity Capital first reported a position in State Street SPDR S&P Biotech ETF in Q3 2017 and held it in 3 quarters.
- NF Trinity Capital's State Street SPDR S&P Biotech ETF position peaked at $10.4M in Q1 2018.
- 431 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2018.
Based on NF Trinity Capital's 13F filing for Q2 2018, filed 7 Aug 2018.